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DOI 10.1186/s12884-015-0458-7RESEARCH ARTICLE Open AccessPlacental inflammation is associated with rural
and remote residence in the Northern Territory,
Australia: a cross-sectional study
Cecelia M O’Brien1,5*, Susan Arbuckle2, Sujatha Thomas1, Jurgen Rode3, Robin Turner4 and Heather E Jeffery4Abstract
Background: The Northern Territory has the highest rates of perinatal morbidity and mortality in Australia. Placental
histopathology has not been studied in this high-risk group of women.
Methods: This is the first study to detail the placental pathology in Indigenous women and to compare the
findings with non-Indigenous women in the Northern Territory. There were a total of 269 deliveries during a
three-month period from the 27th of June to the 27th of August 2009. Seventy-one (71%) percent of all placentas
were examined macroscopically, sectioned then reviewed by a Perinatal Pathologist, blinded to the maternal history
and outcomes.
Results: Indigenous women were found to have higher rates of histologically confirmed chorioamnionitis and or a
fetal inflammatory response compared with non-Indigenous women (46% versus 26%; OR 2.4, 95% CI 1.3-4.5). In
contrast, non-Indigenous women were twice as likely to show vascular related pathology (31% versus 14%; OR 2.77,
95% CI 1.3-5.9). Indigenous women had significantly higher rates of potentially modifiable risk factors for placental
inflammation including genitourinary infections, anaemia and smoking. After adjusting for confounders, histological
chorioamnionitis and fetal inflammatory response was significantly associated with rural or remote residence
(Adjusted OR 2.5, 95% CI 1.08 – 5.8).
Conclusion: This study has revealed a complex aetiology underlying a high prevalence of placental inflammation in
the Northern Territory. Placental inflammation is associated with rural and remote residence, which may represent
greater impact of systemic disadvantage, particularly affecting Indigenous women in the Northern Territory.
Keywords: Placenta, Indigenous women, Pregnancy, Remote, Residence, Genitourinary infections, Anaemia,
Smoking, Histological chorioamnionitis, Fetal inflammatory responseBackground
The Northern Territory (NT) has the highest rates of
perinatal morbidity and mortality in Australia. Women
who identify as Aboriginal or Torres Strait Islander on
average have two to three times the rate of preterm de-
livery, low birth weight and fetal death, along with in-
creased rates of maternal morbidity and mortality in
comparison to non-Indigenous women [1-3].* Correspondence: cecelia.obrien@adelaide.edu.au
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unless otherwise stated.Epidemiological studies have shown high rates of smo-
king [4], remote residence [5] and sexually transmitted
infections [6] in Indigenous women are associated with
poor perinatal outcomes. However, little is known about
the underlying pathology contributing to the high rates
of perinatal morbidity and mortality in the Northern
Territory.
Firstly, high rates of smoking have been reported in
Indigenous women living in urban and rural and remote
areas within the Northern Territory (NT) [1-3,7]. In the
most recent Mothers and Babies report from the NT [7],
50.6% of Indigenous women smoked during the first
20 weeks and 47.7% continued to smoke after 20 weeks
of pregnancy. Wills and Coory found the number of. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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rate of non-Indigenous mothers. Indigenous women who
smoked had a higher rate of low birth weight infants com-
pared to non-Indigenous smokers (5.3% versus 3.7%). The
rate of preterm delivery was marginally increased from
6.1% (in non-Indigenous non-smokers) to 8.3% in Indi-
genous women who smoked [4].
Secondly, there is strong evidence to support the role
of infection and inflammation in the aetiology of prema-
ture rupture of membranes [8], preterm delivery [9] and
stillbirth [10]. Interestingly, high rates of sexually trans-
mitted diseases (20.2%) in Indigenous women have been
associated with low birth weight and perinatal mortality
[6]. Genitourinary infections are modifiable risk factors
that can lead to ascending infection and histological
chorioamnionitis. This stimulates the inflammatory cas-
cade leading to premature rupture of membranes and
preterm delivery [8].
Histological chorioamnionitis is an important and fre-
quent cause of preterm birth, low birth weight and fetal
death. A population based study in Australia by Gordon
and associates in 2011 found that out of 952 fetal deaths,
histological chorioamnionitis was found in 22.6% of cases
[10,11]. In a large cohort of preterm infants born between
20 and 34 weeks in Australia, histological chorioamnioni-
tis was found in 31% of the total 3928 neonates included
in this study [9].
Since the establishment of this causal pathway, the evi-
dence for screening, detecting and treating genitourinary
infections in the prevention of preterm delivery is emer-
ging. Kiss and associates reported one of the first rando-
mised controlled trials investigating the role of a simple
screening program for asymptomatic vaginal infections
in 4155 women in the Vienna in 2001 [12]. Since then,
there have been further trials and now systematic re-
views and meta-analyses that support the use of anti-
biotic treatment of asymptomatic bacteruria [13] and
bacterial vaginosis [14]. A recent systematic review and
meta-analysis has shown a reduction in preterm birth
with the detection and treatment of intermediate flora
or bacterial vaginosis, (two trials including 894 women,
RR 0.54, 95% CI [0.35 – 0.84]) [14,15]. A second syste-
matic review of asymptomatic genital infections in the
prevention or reduction of preterm delivery included
one eligible trial by Kiss and associates (4155 women,
RR 0.48, 95% CI [0.34 – 66]) [12,15]. In both meta-
analyses, preterm delivery rates have been reduced by
40 to 50%. Costs, antibiotic adverse effects and the risk
of antibiotic resistance, remain concerns with ongoing
debate regarding the most effective type and route of
administration (vaginal or oral) [14,15].
Thirdly, a review of the antenatal service in the Northern
Territory found that 27% of Indigenous women were an-
aemic in pregnancy [16], and there is evidence to showthat folate and iron deficiencies affect humoral and cell
mediated immunity [16-19]. In addition, there have been
reports of associations between iron and folate deficiencies
with preterm delivery and low birth weight infants [20,21].
Lastly, 25% of all women who delivered in the Northern
Territory in 2011, resided in rural or remote areas and
89% of these women identified as Indigenous [3]. This
challenges the delivery of adequate and timely maternity
care, education, appropriate nutrition and general health-
care. Lower socioeconomic status in people residing in re-
mote areas of the Northern Territory, has been shown to
influence food choices, contributing to energy dense, nu-
trient poor diets [22]. The most recent epidemiological
study by Steenkamp and associates in 2012 [5], des-
cribes a retrospective review of maternal and perinatal
outcomes, including a multivariate analysis using fac-
tors such as Indigenous status, remoteness and region
within the Northern Territory. This study showed ‘re-
mote-dwelling’ Indigenous mothers had more antenatal
risk factors and poorer outcomes compared with non-
Indigenous women. This included younger age at deliv-
ery, less pain relief in labour, higher caesarean section
rates and longer hospital stays for vaginal births, poorer
neonatal outcomes including higher rates of low birth
weight and preterm births. Remoteness was found to be
an independent risk factor in this study by Steenkamp [5].
Despite the high rates of perinatal morbidity and mor-
tality, there have been no studies examining the placen-
tae from women residing in the Northern Territory or
generally in women who identify as Aboriginal or Torres
Strait Islander within Australia.
We hypothesise that placental inflammation may con-
tribute to the perinatal morbidity and mortality in the
Northern Territory. The aim of this study was to under-
take macroscopic and histological examination of pla-
centas from a cohort of women delivering at the Royal
Darwin Hospital to determine the overall prevalence of
placental pathology in women delivering at the Royal
Darwin Hospital. The second aim was to compare placen-
tal pathology in Indigenous and non-Indigenous women.
The third aim was to correlate placental pathology with
maternal demographics, obstetric and neonatal outcomes.
Methods
This cross-sectional, descriptive study examined placen-
tas from a cohort of women who delivered at the Royal
Darwin Hospital during the 27th of June and the 27th of
August 2009. During this period, there were a total of
270 deliveries and 192 (71%) placentas were examined
as part of the study. Ethics committee review and ap-
proval was obtained from the Human Research Ethics
Committee of the Northern Territory Department of
Health and Families and Menzies School of Health Re-
search with approval number 08/86.
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ton deliveries, greater than 20 weeks gestation or greater
than 500 grams who delivered at Royal Darwin Hospital
during a three month period from June to August 2009.
The only exclusion criterion was multiple pregnancies.
Women were predominately recruited in the postpar-
tum period. Informed written consent was obtained after
their consideration of the information leaflet and discus-
sion with the midwife, researcher, interpreter or Indigen-
ous Liaison Officer. After the delivery, verbal consent for
participation was given to the midwife caring for the
woman and the placenta was placed in a special dedi-
cated fridge in labour ward. Within 24 hours of delivery,
written and informed consent was obtained by the pri-
mary researcher, and the placentas were placed in buffered
formalin in a sealed plastic container and transported to
the Department of Anatomical Pathology. Twenty percent
of women were recruited in the antenatal clinic during
their second and third trimesters visits.
A pilot study examining 24 placentas was conducted
prior to the commencement of the study to ensure quality
assurance of the macroscopic examination of the placenta.
For each placenta, the primary researcher (advanced
obstetric trainee) and the senior pathology registrar per-
formed the macroscopic examination together. All his-
topathology slides were then reviewed by the Head of
Anatomical Pathology to ensure that the sections were
standardised. The placentas were examined, sectioned and
prepared according to the College of American Patholo-
gists (CAP) guidelines [23], based on the Benirschke and
Kaufmann method [24].
A Perinatal Pathologist at the Children’s Hospital at
Westmead (SA) examined 174 (90.6%) placentas for this
study during 2010 and 2011. SA was blinded to all clin-
ical information including the gestation, ethnicity, and
obstetric and neonatal outcome.
There were 18 placentas (9.4%) examined during the
postpartum period for a clinical indication to assist in
the management of the newborn and future pregnan-
cies. These placentas were examined using the same
method as described above in the Department of Ana-
tomical Pathology at the Royal Darwin Hospital by the
Pathology Registrar and reviewed by the Head Anato-
mical Pathologist (JR).
The definitions of placental inflammation were based
on the criteria from Redline and colleagues [25]. Histo-
logical chorioamnionitis is defined as the infiltration of
neutrophils into the amnion and/or chorion in response
to a bacterial infection. The maternal inflammatory re-
sponse starts at the chorionic plate and at the junction
between the decidua and chorion in the first 12 hours.
Within 24 hours, there is migration and spread into the
amnion, enabling the organisms to then enter the amni-
otic cavity. The fetal inflammatory response occurs laterwith migration of fetal neutrophils beginning in the um-
bilical vein or chorionic vessels, migrating over time to
the umbilical arteries and into the Wharton’s jelly. It is
usually clinically silent and is diagnosed by a pathologist
after delivery. Funisitis was defined as the focal infiltra-
tion of neutrophils at the umbilical cord surface and in
the Wharton’s jelly.
The definition of a high-risk pregnancy included
women with significant co-morbidities (essential hyper-
tension, rheumatic heart disease, pre-existing diabetes,
thrombophilia), past or current pregnancy complications
(previous preterm delivery, growth restriction, fetal death,
previous early onset pre-eclampsia, gestational diabetes).
This signified the need for high-risk antenatal care by
an Obstetric team throughout the pregnancy. The def-
inition of low risk pregnancy included women with no
co-morbidities and no past or current pregnancy com-
plications. This group had predominately midwifery
care throughout the pregnancy.
Anaemia was defined as a Haemoglobin level of less
than 110 g/dL.
Rural, Remote and Metropolitan Area (RRMA)
classification: Postcodes and place of residence was col-
lected as part of the demographic data for the study.
Using the RRMA classifications, each participant was in-
dividually classified as metropolitan, rural or remote.
Metropolitan zone is defined as any capital city or centre
with an urban population greater than or equal to
100,000. Rural zone was defined as small or large rural
centre with population ranging between 10,000 and
99,999. Remote zone included remote centres, defined
as greater than 5,000 but less than 10,000 and other re-
mote areas with a population less than 5,000 [26].
Birth weight, head circumference and length percentiles
were obtained from the on-line calculator based NSW
data from Doctor Philip Beeby from Royal Prince Alfred
Hospital in Sydney [27]. The primary reason for the use of
NSW data in preference to the Australian National data
was the access to online calculation generating a precise
percentile calculation rather than an estimate or a range.
The sample size was calculated based on the baseline
prevalence of chorioamnionitis in term pregnancies in a
large cohort study by Russell and associates from Royal
Prince Alfred Hospital in 1979 [28]. Our assumption
was that there would be increased rates of chorioam-
nionitis in our study compared with the population of
women in Sydney. Using a power of 80% to detect a
difference in the rate of chorioamnionitis of 25% (5%
versus 30%), assuming a significance level of p < 0.05.
The minimal sample size calculated was 86 (43 in each
group). Using a proportion of 2:1 (non-Indigenous com-
pared with Indigenous births), the sample size was 102
(68 placentas in non-Indigenous women and 34 in Indi-
genous women).
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The demographic data in this study was analysed using
the t-statistic for continuous variables and the chi-squared
statistic for dichotomous and nominal variables. Multi-
variate analysis was undertaken to assess the impact of
ethnicity on placental inflammation after adjusting for
perinatal factors. These factors included maternal age, ges-
tational age, smoking, prolonged ruptured membranes, lo-
cation (rural/remote versus metropolitan), genitourinary
infection and anaemia. There were five categories for
gestation in completed weeks: 20 – 36 weeks, 37 weeks,
38 weeks, 39 weeks and 40 and above weeks. Age was
used as a continuous variable within the model. The final
model was developed using stepwise logistic regression.
Odds ratio and adjusted odds ratio with 95% confidence
intervals were reported. All P-values were two sided at a
significance level of P < 0.05. Analyses were conducted in
SPSS version 19.0.0 [29] and R Program [30].
Results
During the study period between the 26th of June and
the 27th of August 2009, there were 269 women who de-
livered 269 singleton newborns. One hundred and
ninety-two mothers and newborns were included in the
cross-sectional study, representing 71% of all deliveries
in this time period. There were no significant differences
in the birth statistics of women included in the study in
comparison to women who were not included in theFigure 1 Flow chart for this cross-sectional study. There were 269 sing
the 27th of August 2009. Seventy-seven placentas were not included for re
(16) or discarding of placentas post delivery (37) and other reasons (16). A
the entire cohort of deliveries. There were no statistically significant differen
study. A perinatal pathologist, blinded to outcome, gestation and ethnicity
clinical reasons in the Department of Anatomical Pathology, Royal Darwinstudy as shown in Figure 1. This included age, ethnicity,
parity, location of usual residence, mode of delivery,
birth weight, gestation and sex of the infant. Figure 1
shows the flow chart for the Placental study. Of the 192
women included in the study, 18 (9.4%) of placentas
were sent for histopathology at the Royal Darwin Hos-
pital for clinical reasons such as perinatal mortality, fetal
distress, preterm delivery, low apgars and clinical signs
of chorioamnionitis.
All baseline characteristics for Indigenous and non-
Indigenous women included in this study are shown
below in Table 1. In this study, 59 (30.7%) out of the 192
placentas did not show any pathology. An inflammatory
response in the amnion or chorion or umbilical cord
was found in a total of 65 placentas (33.9%). Fourty-six
placentas (24%) showed vascular pathology as the pri-
mary finding. Confirmed villitis and related pathology
was found in 13 (6.8%) cases.
There was a significant association between placental
inflammation and ethnicity (χ2 = 8.5, df = 1, p = 0.004) as
shown in Figure 2. Thirty-six Indigenous women (45.6%)
were found to have confirmed inflammation on placental
examination in comparison to 29 of non-Indigenous wo-
men (25.7%). Indigenous women were twice as likely to
have histological chorioamnionitis and or a fetal inflam-
matory response (OR 2.43 with 95% CI 1.3 to 4.5).
There was a significant association between the vascu-
lar pathology and ethnicity (χ2 = 7.42, df = 1, p = 0.006).leton deliveries during the study period between the 27th of June and
asons including declined consent (8), discharge home prior to consent
total of 192 placentas were included in this study, representing 71% of
ces when comparing women included with those excluded from the
, reviewed over 90% of the placentas. Nine percent were examined for
Hospital.








N = 79 N = 113
Maternal Age (years) – median (IQR) 27 (22–32) 26 (22–32) 0 P = 0.43
Parity – median (IQR) 2 (1 – 3) 1 (0 – 2) 1 P < 0.0001**
Area of residence (RRMA)
Metropolitan 18 (22.8) 97 (85.8) 0 Analysis of
Rural 4 (5.1) 13 (11.5) 0 Metro vs Rural and Remote P < 0.0001**
Remote 57 (72.2) 3 (2.7) 0
Smoking 37 (46.8) 35 (31) 30 (16) P = 0.03*
BMI < 20 (kg/m2) 3 (3.8) 1 (0.9) 83 (43) P = 0.04*
BMI > 30 (kg/m2) 10 (26.5) 30 (12.6) 83 (43) P = 0.02*
Pregnancy related
Antenatal Care (less than 4 visits) 11 (13.9) 2 (1.8) 1 (0.5) P = 0.001*
High risk classification 46 (58.2) 25 (22) 0 P < 0.0001**
Gestational Diabetes 13 (16.5) 4 (3.5) 22 (11.5) P = 0.002*
Hypertension 11 (13.9) 21 (18.6) 8 (4.2) P = 0.39
Anaemia 13 (16.5) 5 (4.4) 0 P = 0.005*
Candida culture positivity 24 (30.4) 4 (3.5) 0 P < 0.0001**
Urinary tract infection 15 (19) 7 (6.2) 0 P = 0.006*
GBS positivity (3rd Trimester) 13 (24.5) 21 (21.4) 41 (21.4) P = 0.6
Sexually transmitted disease (1st Trimester) 13 (16.5) 1 (0.9) 97 P < 0.0001**
Mode of Delivery 0 Analysis of Vaginal vs LSCS P = 0.03*
Spontaneous Vaginal Delivery 48 (61) 80 (71)
Instrumental Vaginal Delivery 4 (5.1) 10 (8.8)
Emergency LSCS 18 (23) 15 (13.3)
Elective LSCS 9 (11.4) 8 (7)
Neonatal Outcomes
Gestation (weeks) – median 39 wks 39.5 wks 0 P = 0.005*
Preterm deliveries (%) < 34 wks 8 (10.1) 3 (2.7) P = 0.03*
<37 wks 12 (15.2) 8 (7.1) P = 0.07
Birth weight (grams) – median 3215 grams 3365 grams 0 P = 0.01*
Low birth weight < 2500 gms (%) 15 (19.0) 10 (8.8) 0 P = 0.04*
Small for Gestational Age (<10th) 12 (15.2) 10 (8.8) 13 (6.8) P = 0.18
Large for Gestational Age (>90th) 10 (12.6) 9 (7.9) 13 (6.8) P = 0.27
Admission into the NICU 27 (34.2) 21 (18.6) 6 (3.1) P = 0.02*
NB: Denominator for each column = N, numerator = n, % is the percentage of the numerator/denominator for each column. There is missing data for some of
these categories and the statistical analysis included all missing data in the denominator.
*P = 0.05 – 0.0001, **P < 0.0001.
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cular primary pathology compared with 11 Indigenous
women (13.9%). The odds ratio was 2.78 (95% CI 1.3
and 5.9).
The overall prevalence of histological chorioamnionitis
was 33.9% in this cross-sectional study of women deliv-
ering at the Royal Darwin Hospital. The term placental
inflammation rate was 32.6% (56 out of a total of 172term infants). The overall prevalence of chorioamnionitis
in women residing in urban Darwin was 24.3% (n = 115)
and in women classified as low risk, the prevalence was
33.1% (n = 121). When these three factors were com-
bined, 88 women were term, low risk and lived in urban
Darwin. The baseline rate of histological chorioamnioni-
tis with or without a fetal inflammatory response in this
group of women was 25.6%.
Figure 2 Prevalence of primary placental pathology according to ethnicity (N = 192). The X-axis depicts the 4 types of primary placental
pathology with the total number of women in each group below. The Y-axis is the percentage of cases in each pathology group based on ethnicity
with the denominator being the total number of women in each ethnicity group (Indigenous = 79, Non-Indigenous = 113). The percentage of cases in
each pathology group is shown inside the columns. There was a significant difference in the prevalence of placental inflammation in Indigenous
women compared with non-Indigenous (45.6% vs 25.7%). In contrast, non-Indigenous women had a higher prevalence of vascular pathology
compared with Indigenous women (30.1% vs 13.9%). There were no differences in the ‘No Pathology’ and ‘Other’ pathology comparing Indigenous
women to non-Indigenous women.
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preterm infants). There was no association between the
presence of chorioamnionitis and all preterm delivery
(χ2 = 1.802, df = 1, P = 0.18) or spontaneous preterm
delivery (χ2 = 3.03, df = 1, P = 0.08). Figure 3 illustrates
higher rates of histological chorioamnionitis and fetal
inflammatory response at the extremes of gestation,
below 28 weeks and 40 weeks and above.
Table 2 shows the results of the univariate analysis of
histological chorioamnionitis with or without a fetal in-
flammatory response and the association with multiple
variables including potential risk factors and pregnancy
outcomes.
The fetal inflammatory response was present in 46
(70.8%) out of the 65 cases showing placental inflam-
mation. The more severe response defined as funisitis,
occurred in 27 of the total 46 cases with a confirmed
fetal inflammatory response (48.7%). There was a sig-
nificant increase in the rate of funisitis in Indigenous
women (20.3%) compared with non-Indigenous women
(9.7%) (χ2 = 8.14, p = 0.04). The odds ratio was 2.08 (95%
CI 1.02 - 4.24), indicating that Indigenous women have
twice the rate of funisitis compared with non-Indigenous
women.
There were a total of 71 high-risk pregnancies and 121
low risk pregnancies in this study. There were no differ-
ences in placental inflammation when women classified
as high risk (35.2%) were compared with women whowere classified as low risk (33.1%) (χ2 = 0.93, p = 0.7).
When all high-risk pregnancies were excluded from the
analysis, a reanalysis was performed of low risk pregnan-
cies alone. There were significant differences in placental
inflammation for Indigenous women (51.5%) when com-
pared with non-Indigenous women (26.1%) (χ2 = 6.985,
P = 0.008). The odds ratio was 3.0 (95% CI 1.31 – 6.9)
indicating in low risk pregnancies, Indigenous women
were three times more likely to show placental inflam-
mation compared with non-Indigenous women.
Women who resided in Darwin and outer surrounding
suburbs were included in a specific analysis (n = 115), with
exclusion of women living rurally or remotely (n = 77).
There were a total of 28 cases of placental inflammation
with an overall prevalence of placental inflammation to
be 24.3%. There were no significant differences in the
prevalence of placental inflammation in Indigenous wo-
men (22.2%) compared to non-Indigenous women (24.7%)
(χ2 = 0.52, P = 0.89), whose place of residence and primary
catchment area was Darwin and surrounding suburbs.
There were a total of 60 (31.3%) women who were clas-
sified as living remotely using the RRMA classification.
There were 132 women who were non-remote (68.8%).
Indigenous women more likely to live remotely (57 of 79,
72.2%) and non-Indigenous women were more likely to
live in non-remote areas of the Northern Territory (110 of
113, 97.3%). Placental inflammation occurred in 51.7%
women who lively remotely compared with 25.8% who
Figure 3 Prevalence of histological Inflammation according to gestation and ethnicity. This graph demonstrates a bimodal relationship
with gestation and placental inflammation. At the extremes of gestation, placental inflammation less than 28 weeks is over 60% and for women
delivering at 40 weeks and beyond, the prevalence is approximately 40%. Between 37 and 39 completed weeks, the prevalence of histological
chorioamnionitis reaches the minimal value of 24%. The fetal inflammatory response including funsitis is more pronounced at the extremes of
gestation, and was absent in women delivering between 28 and 33 completed weeks.
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odds ratio was 3.08 (95% CI 1.6 – 5.8), indicating that
women who lived remotely had three times the prevalence
of placental inflammation compared with women living in
metropolitan or rural areas.
The multivariate analysis is shown in Table 3 and the
model was adjusted for confounders including gestation,
maternal age, premature rupture of membranes greater
than 48 hours and rural or remote residence. There was
no difference in placental inflammation comparing Indi-
genous to non-Indigenous women after adjusting for
confounders (Adjusted OR 1.62 [0.68 – 3.84]). Interest-
ingly, women who lived in rural and remote residences
had a 2.5 times increased risk of developing placental in-
flammation (Adjusted OR 2.5 [1.08 – 5.84]).
Discussion
This is the first study to comprehensively describe pla-
cental pathology from women delivering at the Royal
Darwin Hospital, a tertiary referral centre in the Top
End of the Northern Territory.
In this study, 32.6% of placentas from women delivering
at term showed inflammation of the amnion, chorion or
umbilical cord. A detailed analysis was performed to de-
termine the baseline prevalence of placental inflammation
in low risk, term women in this study who lived in the
primary catchment area for Royal Darwin Hospital. The
overall prevalence of histological chorioamnionitis inwomen residing in urban Darwin was 24.3% (n = 115);
in women delivering at term was 32.6% (n = 172) and in
low risk women was 33.1% (n = 121). Combining the
three variables resulted in 88 women who were term,
low risk and lived in Darwin and the baseline preva-
lence of placental inflammation was 25.6%.
The most recent study reporting the prevalence of
chorioamnionitis in term pregnancies, examined 1012
placentas as part of a population based Auckland Birth
weight Collaborative (ABC) study in New Zealand, 2010.
The overall prevalence of histological chorioamnionitis
was found to be 14.3%, with maternal inflammation
alone contributing to over 50%, both maternal and fetal
inflammation found in 45.5% and fetal inflammation
alone in 2.8% [31]. In comparison to our current study,
we found an increased prevalence of HCA and fetal in-
flammatory response (66%), with less HCA alone (29%)
and a small increase in fetal inflammation alone (4.6%).
In the ABC study, there were higher incidences of amnioni-
tis in women who identified as Chinese (25.8%, n = 93),
Maori (21.5%, n = 65) and Pacific Islanders (16.4%, n = 122)
compared with European (12.2%, n = 555) women in the
multivariate analyses. Interestingly, ethnic differences in the
ABC study persisted after adjusting for confounders [31].
The prevalence of histological chorioamnionitis in our
study was 1.5 times the prevalence reported in the re-
cent ABC study in New Zealand [31] and over 5 times
the rate reported in a cohort study in RPA in 1979 [28].
Table 2 Univariate analysis of the perinatal risk factors associated with placental inflammation
Perinatal Factors Total Missing data Placental inflammation P value
N = 192 N = 65
n (%) n (%)
Maternal Age (years)
Median (inter-quartile range) 0 24 (21 – 31) P = 0.04*
27 (23 – 32)
No inflammation
Parity P = 0.07
Nulliparous 60 (31.4) 0 26 (43.3)
Multiparous 131 (68.6) 39 (29.8)
Residence P < 0.0001** P = 0.001*
Metropolitan 115 (59.9) 0 28 (24.3)
Rural 17 (8.9) 0 6 (35.3)
Remote 60 (31.3) 0 31 (51.7)
Metropolitan and Rural versus Remote 132 (68.8) 0 34 (25.8)
Rural and Remote vs Metropolitan 77 (40) 0 37 (56.9)
Ethnicity P = 0.004*
Indigenous 79 0 36 (45.6)
Non-Indigenous 113 0 29 (25.7)
High risk P = 0.8
Yes 71 (37) 0 25 (35.2)
No 121 (63) 0 40 (33.1)
Less than 4 antenatal visits P = 0.8
Yes 13 (6.8) 0 4 (30.8)
No 178 (92.7) 1 60 (34.3)
Anaemia P = 0.04*
Yes 18 (9.4) 0 10 (55.6)
No 174 (90.6) 55 (31.6)
BMI ≤ 20 kg/m2 P = 0.04*
Yes 4 (2.1) 83 (43.2) 3 (75)
No 105 (54.7) 29 (27.6)
BMI ≥ 30 kg/m2 P = 0.23
Yes 40 (20.8) 83 (43.2) 9 (22.5)
No 69 (35.9) 23 (33.3)
Smoking P = 0.076
Yes 72 (37.5) 30 (15.6) 30 (41.7)
No 90 (46.9) 35 (29.2)
1st Trimester Genitourinary positive culture P = 0.057
Yes 57 (29.7) 97 (50.5) 25 (38.5)
No 38 (19.8) 40 (29.6)
Candida culture positivity P = 0.05*
Yes 28 (14.6) 0 14 (50)
No 164 (85.4) 51 (31)
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Table 2 Univariate analysis of the perinatal risk factors associated with placental inflammation (Continued)
Urinary Tract Infection P = 0.09
Yes 22 (11.5) 0 11 (50)
No 170 (88.5) 54 (31.8)
Sexually transmitted disease P = 0.9
Yes 14 (7.3) 97 (50.5) 5 (35.7)
No 81 (42.2) 60 (33.7)
Any Genitourinary culture positivity P = 0.5
Yes 70 (40.9) 21 (10.9) 26 (37.1)
No 101 (59.1) 30 (29.7)
GBS positivity P = 0.6
Yes 34 (22.5) 41 (21.4) 13 (38.2)
No 117(77.5) 52 (32.9)
Rupture of membranes > 48 hrs P = 0.004*
Yes 9 (4.7) 0 7 (77.8)
No 183 (95.3) 0 58 (31.7)
Denominator for each column = N, numerator = n, % is the percentage of the numerator/denominator for each column.
Missing data was not excluded in the denominator. *p = 0.05 – 0.001, **p < 0.001.
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reported to be 3.8% for 37 to 40 weeks and 5.1% for 41
to 44 weeks gestation [28]. Comparatively, international
data from a 16-year retrospective study of placental
histopathology in Hungary revealed subclinical acute
chorioamnionitis occurred in 5.1% of term pregnancies
compared with 30% in preterm pregnancies [32].
Differences in the prevalence of histological chorioam-
nionitis could be due to the wide range of sampling
techniques and diagnostic criteria. The ABC study [31]
only sampled the chorionic vessels and placental paren-
chyma and did not perform a membrane roll to assess
the chorion and amnion separately or sample the um-
bilical cord to assess the extent of the fetal inflammatory
response. The RPA study [28] used similar sampling
techniques including a membrane roll but used one
sample of the umbilical cord. In our study, we per-
formed a membrane roll and obtained 2 samples of theTable 3 Multivariate analysis of Placental inflammation
Regression model Unadjusted odds rati
Gestation 0.96 (0.88 – 1.04)
Maternal age 0.95 (0.9 – 0.997)
Prolonged rupture of membranes > 48 hours 7.5 (1.52 – 5.3)
Residence
Rural and remote versus Metropolitan 2.9 (1.55 – 5.3)
Ethnicity
Indigenous vs Non-Indigenous 2.4 (1.3 – 4.5)
Multivariate analysis was undertaken to assess the impact of ethnicity on placental
maternal age, gestational age, smoking, prolonged ruptured membranes, location (
were five categories for gestation in completed weeks; 20 – 36 weeks, 37 weeks, 38
variable within the model. The final model was developed using stepwise logistic reumbilical cord, one from the fetal end and one from
the chorionic end.
Potential mechanisms underlying the higher pre-
valence of histological chorioamnionitis in this study
include ascending infection, immune function, malnu-
trition and systemic disadvantage. There were trends
towards significance for 1st trimester genitourinary in-
fections and significant differences for candida and pla-
cental inflammation in our study (Table 2). There was a
moderate quantity of missing data for 1st trimester gen-
itourinary testing and this was predominately in the
non-Indigenous women from the primary catchment
area. However, the majority of women had a 3rd trimes-
ter low vaginal swab for group B streptococcus screen-
ing (Table 2). Interestingly, Indigenous women had a
significantly higher rate of culture positive candidiasis
(30.4% vs 3.5%) and urinary tract infections (19% versus
6.2%) compared with non-Indigenous women.o (95% CI) Adjusted odds ratio (95% CI) Significance
0.17 (0.06 – 0.55) P = 0.002
0.95 (0.89 – 0.998) P = 0.04
10.5 (1.73 – 63.8) P = 0.009
P = 0.03
2.5 (1.08 – 5.84)
P = 0.28
1.62 (0.68 – 3.84)
inflammation after adjusting for perinatal factors. These factors included
rural/remote versus metropolitan), genitourinary infection and anaemia. There
weeks, 39 weeks and 40 and above weeks. Age was used as a continuous
gression.
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ment of women with abnormal vaginal flora reduced the
risk of preterm delivery by 47% (2 trials, n = 894, RR 0.53
[0.34-0.84]) [14]. In our study, the prevalence of candidia-
sis was 14.6%, and was associated with placental inflam-
mation. This rate is comparable to the large randomised
controlled trial by Kiss and colleagues in Vienna in 2004,
where a simple screening program for abnormal vaginal
flora was shown to reduce the rate of preterm delivery by
50% [33]. Ongoing studies, examining the treatment of
candida and the effect on preterm delivery rates, are being
conducted [33]. A well-designed, randomised controlled
trial would be the next step to determine if screening and
treatment of genitourinary infections in each trimester
could reduce chronic or recurrent genitourinary infection,
powered to assess clinical outcomes such as preterm deliv-
ery and include histopathology to determine underlying
placental inflammation.
Poor nutrition and smoking have been postulated to
cause low folate levels and the former iron deficiency that
may underlie the high rates of anaemia in Aboriginal and
Torres Strait Islanders [34]. In our study, anaemia was re-
ported to be present in 16.5% of Aboriginal and 4.4% of
non-Aboriginal pregnant women. Anaemia was also sig-
nificantly associated with the presence of placental inflam-
mation. Naeye and colleagues found that in Ethiopian
women, amniotic fluid infection was higher in those who
were malnourished and impoverished [35]. Host defense
factors that normally exist to prevent infection were re-
duced in malnourished pregnant women [36]. In the devel-
oping world, poor nutrition and sub-optimal antenatal care
is associated with a higher incidence of infection [37]. This
study did not test for micronutrient deficiencies or dietary
factors in pregnancy, but further study in this area may
help to identify potentially reversible factors that may im-
pact the onset and chronicity of placental inflammation.
Remoteness could be a proxy for other factors such as
socioeconomic disadvantage including education, hous-
ing, employment and income [5]. The multivariate ana-
lysis showed ethnicity is not associated with placental
inflammation after adjusting for confounders. Interest-
ingly, rural and remote residence remained significant
risk factors. The multivariate analysis incorporated tests
for co-linearity with no significant effect between ethni-
city and residency. Graham and colleagues postulate that
‘systemic disadvantage’ rather than suboptimal care in
pregnancy is likely to be the cause of inequalities seen in
perinatal outcomes for Indigenous women living in rural
and remote areas in Australia [38]. This was supported
in our study were there were no associations with sub-
optimal antenatal care and placental inflammation.
The relationship with gestation is an interesting finding.
From the literature, there is an inverse and linear relation-
ship between chorioamnionitis and preterm gestation [9].Russell and associates found high rates of acute chorioam-
nionitis in 94% cases between 21-24 weeks, 40% in 25 – 28
weeks, 35% between 29 – 32 weeks and 10% in 33 – 36
weeks, 3.8% at term and 5.1% over 40 weeks [28]. There
have been two recent studies examining cases of fetal death
that have shown a bimodal relationship with gestation
[10,11]. In 2007, Lahra and colleagues reported a bimodal
relationship with gestation in a 15-year hospital cohort
study examining placental inflammation and fetal death
[11]. The rate of chorioamnionitis in extreme premature
and post mature gestations was over 50% with an overall
rate of 36.9%. A population cohort study of fetal deaths
in Australia between 2002 and 2004 found the incidence
of histological chorioamnionitis to be 22.6% and fetal in-
flammatory response was 10.1%, most pronounced after
40 weeks gestation. Both studies found that the fetal inflam-
matory response was associated with spontaneous labour
and the lack of this response was associated with an unex-
plained fetal death [10,11]. There is good evidence to sup-
port that infection and inflammatory changes contribute to
onset of labour in preterm deliveries [8]. There remains un-
certainty concerning histological chorioamnionitis and fetal
inflammatory response during the term and post-term
period. Hypotheses include a reaction to meconium
[39,40], prolonged rupture of membranes [41], coitus [42],
progressive cervical effacement [43], cervical dilatation and
multiple vaginal examinations in labour [44]. At least two
studies have found that meconium stained amniotic fluid
and neonatal morbidity is associated with placental inflam-
mation [39,40]. There is some evidence to support that the
hypothesis that meconium may predispose and increase the
incidence of infection and related histological placental in-
flammation [10,11,40]. In our study, there was no difference
in the presence of meconium and placental inflammation
(10.4% compared with 14.2% with no inflammation) nor
were there differences in neonatal outcomes (Table 4).
An interesting finding in this cross-sectional study
was the contrast in the placental pathology for Indi-
genous and non-Indigenous women. Non-Indigenous
women showed significantly higher rates of vascular
primary pathology (31%) compared with Indigenous
women (14%). This included maternal under perfusion,
infarction, thrombus, retroplacental haematoma and
abruption. Reasons for this difference may relate to the
differences in vascular related risk factors in non-
Indigenous women. In this study, non-Indigenous women
had significantly higher levels of obesity classified as body
mass index (BMI) greater than 30 m2/kg (26.5% vs 12.6%)
and increased rates of hypertension (essential and preg-
nancy related) compared to Indigenous women (18.9%
versus 13.9%).
The main limitation of our study was the lack of statis-
tical power to examine important outcomes such as pre-
term delivery in the setting of placental inflammation.
Table 4 Perinatal outcomes relating to the presence of placental inflammation
Total No inflammation Placental inflammation P value
N = 192 N = 127 N = 65
n (%) n (%) n (%)
Intrapartum
Clinical syndrome 7 (3.6) 1 (0.8) 6 (9.2) P = 0.003*
Intrapartum fever 9 (4.7) 2 (1.6) 7(10.8) P = 0.004*
Fetal distress 56 (29.2) 35 (27.6) 21 (32.3) P = 0.5
Meconium 25 (13) 18 (14.2) 7 (10.8) P = 0.5
Caesarean Section 50 (26) 25 (19.6) 15 (23.1) P = 0.5
Postnatal
Endometritis 11 (5.7) 9 (7.1) 2 (3.1) P = 0.3
Fever/Sepsis 24 (12.5) 12 (9.4) 12 (18.5) P = 0.07
Neonatal
Apgar < 4 at 5mins 8 (4.2) 4 (3.1) 4 (6.2) P = 0.3
PTB < 37 weeks 20 (10.4) 11 (8.7) 9 (13.8) P = 0.3
Spontaneous PTB 17 (8.9) 9 (13.8) 8 (6.3) P = 0.08
SGA < 10th centile 22 (11.5) 14 (11) 8 (12.3) P = 0.8
LGA > 90th centile 16 (8.3) 14 (11) 2 (3.1) P = 0.06
Less than 50th centile 100 (52.1) 63 (49.6) 37 (56.9) P = 0.2
Admission to NICU 50 (26.9) 32 (25.2) 18 (27.7) P = 0.7
Suspected sepsis 42 (21.9) 25 (19.7) 17 (26.2) P = 0.3
Confirmed sepsis 5 (2.6) 3 (2.4) 2 (3.1) P = 0.8
Perinatal Mortality 7 (3.6) 3 (2.4) 4 (6.2) P = 0.2
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every placenta for the entire cohort of women delivering
at Royal Darwin Hospital during this time period. Our
study included 71% (192 out of 269) of all women who
delivered in a 3 month time period. There were no sta-
tistically significant differences in the women who were
included and those who were not included in this study.
The third limitation relates to a high perinatal death
noted in this study group compared with the yearly aver-
age. All fetal and neonatal deaths for this time period
meet the inclusion criteria and had mandatory placental
histopathology. The proportion of fetal and neonatal
deaths in this three-month period is likely to represent
chance rather than a significantly different group of
women compared with the current population in the
Top End of the Northern Territory. We also recommend
further studies in Australia to test the reliability of our
findings.
This study has described the complexity of placental
inflammation in the Northern Territory and the cause
may not be as simple as ascending infection alone.
Anaemia, socioeconomic disadvantage, high rates of
smoking and genitourinary infection are all likely to
contribute to the prevalence of placental inflammation
seen in this cohort of women in the Northern Territory.Further studies are required to understand the impact
of genitourinary infections, anaemia and remote residence
on rates of placental inflammation, powered to assess peri-
natal outcomes such as preterm delivery and low birth
weight. Until we can achieve equity with housing, income,
education, nutrition and access to healthcare, systemic
disadvantage remains the greatest challenge for Indigen-
ous women and their babies in the Northern Territory.
Conclusion
This is the first study to describe the prevalence of pla-
cental pathology in the Northern Territory, Australia.
The findings of this study are important in understand-
ing the factors that contribute to the high rates of peri-
natal morbidity and mortality in the Northern Territory.
This study found a high prevalence of subclinical, his-
tological chorioamnionitis and fetal inflammation in
both preterm and term deliveries. Potential modifiable
factors were identified including anaemia and genitou-
rinary infections such as candida. After adjusting for
confounders, rural and remote residence was associated
with placental inflammation, which may represent a grea-
ter impact of systemic disadvantage for women living in
rural and remote Northern Territory. This study provides
optimism that perinatal health may improve by correcting
O’Brien et al. BMC Pregnancy and Childbirth  (2015) 15:32 Page 12 of 13the socioeconomic disadvantage for women living in re-
mote areas of the Northern Territory.
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